Hodgkin Lymphoma Diagnosis and Epidemiology
Age-Specific Epidemiologic Considerations
- The American Joint Committee on Cancer recommends considering age-specific epidemiology when diagnosing lymphoma, as DLBCL incidence is extremely low in young adults, with rates of only 0.3/100,000 per year in the 35-39 age group, increasing dramatically with age to 26.6/100,000 in those 80-84 years old 1, 2
- The National Comprehensive Cancer Network notes that the median age for DLBCL diagnosis is typically in the 6th-7th decade of life, with the disease being uncommon in patients under 40 3
Clinical Features That Support Hodgkin Lymphoma
- The American College of Physicians suggests that pruritus is a classic B-symptom more characteristic of Hodgkin lymphoma than DLBCL, though both can present with constitutional symptoms 4
Critical Diagnostic Pathway
- The European Society for Medical Oncology recommends that excisional lymph node biopsy is mandatory and represents the gold standard for distinguishing between these entities, as morphology and immunophenotyping are completely different 3, 5
- The College of American Pathologists notes that the biopsy must be sent fresh in saline to allow for flow cytometry, immunohistochemistry, and molecular studies 4, 3
- The World Health Organization suggests that the minimum immunohistochemistry panel must include CD45, CD20, CD3, and CD15/CD30 to distinguish DLBCL (CD20+, CD30-) from classical Hodgkin lymphoma (CD15+/CD30+, CD20-) 3, 2
Important Caveats in Young Patients
- The American Society of Clinical Oncology notes that while Hodgkin is more likely, DLBCL can occur in young adults, particularly in the setting of immunosuppression, HIV infection, or EBV-positive status 3
- The National Institute of Health suggests that primary mediastinal B-cell lymphoma (PMBCL), a variant of DLBCL, has a predilection for young women in their 30s-40s and should be considered if mediastinal involvement is present 3